Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
2000-01-04
2000-12-05
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, A61K 31415
Patent
active
061567795
ABSTRACT:
The present invention provides methods for treating Cryptococcus neoformans and Candida albicans in a subject in need of such treatment. The methods comprises administering to the subject a dicationic bis-benzimidazole in an amount effective to treat the conditions.
REFERENCES:
patent: 4156778 (1979-05-01), Rosner et al.
patent: 4933347 (1990-06-01), Tidwell et al.
patent: 4963589 (1990-10-01), Tidwell et al.
patent: 5134152 (1992-07-01), Takeshiba et al.
patent: 5212197 (1993-05-01), Dolman et al.
patent: 5278182 (1994-01-01), Fujishima
patent: 5304653 (1994-04-01), Brayer et al.
patent: 5362910 (1994-11-01), Makino et al.
patent: 5428051 (1995-06-01), Tidwell et al.
CA93: 95 273, Roesner et al, Apr. 3, 1980.
CA 90: 38 914, Roesner et al, Sep. 2, 1978.
T.M. Cresp and M.V. Sargent; Synthesis and Paratropicity of Heteroatom-bridged [17] Annulenones; J.C.S. Perkin Ipp. 2961-2971 (1973).
O. Dann et al; Trypanocide Diamidone mit drei isolierten Ringsystemen; Liegibs Ann. Chem. pp. 160-194 (1975).
B.P. Das and D.W. Boykin; Synthesis and Antiprotozoal Activity of 2,5-Bis (4-guanylphenyl ) thiophenes and-pyrroles; J. Med. Chem. 20, pp. 1219-1221 (1977).
B.P. Das and D.W. Boykin; Synthesis and Antiprotozoal Activity of 2,5-Bis (4-guanylphenyl) Furans; J. Med. Chem. 20, pp. 531-536 (1977).
K. Grossgebauer; A New Fluorescense Technique for Staining of Mononuclear Phagocytes, Blut 39, pp. 281-283 (1979).
B.P. Das et al; Synthesis and Antirypanosomal Activity of Some Bis (4-guanylphenyl) Five-and Six-Membered Ring Heterocycles; J. Med. Chem. 23, pp. 578-581 (1990).
S. Kumar et al; Possible Anthelmintic Agents: Syntheses of Ethyl 5 (6)-[5(6)-Substituted-2-benzimidazolyl]benzimidazole-2-carbamates & Ethyl 4,6-Dinitro-5-substituted-amino-benzimidazole-2-carbamates; Indian J. Chem. 20B, pp. 254-260, Mar. (1981).
B.J. Das et al; 1,4-Bis (4-guanylphenylethyl) benzenes as Potential Antitrypanosomal Agents; J. of Pharmaceutical Sciences 71, No. 4, p. 465 Apr. (1982).
D. Bonne et al; 4', 6-Diamidino-2-phenylindole, a Fluorescent Probe for Tubulin and Microtubules; J. of Biological Chemistry 260, No. 5, pp. 2819-2825 Mar. (1985).
C.H.C.M. Buys et al; A comparison of the effect of 5-bromodeoxyuridine substitution of 33258 Hoechst-and DAPI-fluorescence of isolated chromosomes by bivariate flow karyotyping; Histochemistry 84, pp. 462-470 (1986).
J. Bonaly et al; A Flow Cytometric Study of DNA Staining In Situ in Exponentially Growing and Stationary Euglena gracilis; Cytometry 8, pp. 42-45 (1987).
A. Babu and R.S. Verma; Expression of heterochromatin by restriction endonuclease treatment and distamycin A/DAPI staining of Indian muntjac (Muntiacus muntjak) chromosomes; Cytogenet Cell Genet 41; pp. 96-100 (1986).
I. Mayakawa et al; Isolation of morphologically intact mitochondrialnucleoids from the yeast, Saccharomyces cerevisiae; J. of Cell Science 88, pp. 431-439 (1987).
G. Bottiroli et al; DNA Double Staining for a Fluorescence Energy Transfer Study of Chromatin in Liver Cells; Cell Biophysics 15, pp. 249-263 (1989).
I. Kapuscinski; Interactions of Nucleic Acids with Fluorescent Dyes: Spectral Properties of Condensed Complexes; J. of Histochemistry and Cytochemistry 38, No. 9, pp. 1323-1329 (1990).
C. Parolin et al; The effect of the minor groove binding agent DAPI (2-amidino-diphenyl-indole) on DNA-directed enzymes: an attempt to explain inhibition of plasmid expression in Escherichia coli, FEMS Microbiology Letters 68; pp. 341-346 (1990).
M. Montag et al; Working with the confocal scanning UV-laser microscope; specific DNA localization at high sensitivity and multiple-parameter fluorescence, J. of Microscopy, 163, pp. 201-210 (1991).
S. Mohan and N. Yathindra; Flexibility of DNA in 2:1 Drug-DNA Complexes-Simultaneous Binding of Two DAPI Molecules to DNA: J. of Biomolecular Structure & Dynamics 9, pp. 695-704 (1991).
A. Myc et al; DNA Stainability in Aneupolid Breast Tumors: Comparison of Four DNA Fluorochromes Differing in Binding Properties; Cytometry 13, pp. 389-394 (1992).
A. L. Rayburn, et al; SHORT NOTE Estimating Percentage Constitutive Heterochromatin by Flow Cytometry; Experimental Cell Research 198, pp. 175-178 (1992).
W. D. Wilson et al; The Search for Structure-Specific Nucleic Acid-Interactive Drugs Effects of Compound Structure of RNA versus DNA Interaction Strength, Biochemistry 32, pp. 4098-4104 (1993).
K. Jansen et al; Binding of DAPI Analogue 2,5-Bis (4-amidinophenyl) furan to DNA; Biochemistry 32, pp. 6605-6612 (1993).
H.H.Q. Heng and L,-C Tsui; Modes of DAPI banding and simultaneous in situ hybridization C. Springer-veriag (1993).
T.A. Fairley et al; Structure, DNA Minor Groove Binding, and Base Pair Specifity of Alkyl-and Aryl-Linked Bis (amidinobenzimidazoles) and Bis (amidinoindoles), J. Med. Chem. 36, pp. 1746-1753 (1993).
C. C. Dykstra et al; Synthesis and Characterization of a Novel Series of AromaticDicationic Furans With DNA-Specific Fluorescense Properties; pp. 1-7 Feb. (1994).
Human Cytogenetics vol. I Constitutional Analysis: A Practical Approach Oxford University Press, pp. 1-211.
W. D. Wilson et al; The Effects of Ligand Structure on Binding Mode and Specificity in the Interaction of Unfused Aromatic Cations with DNA; Molecular Basis of Specifics in Nucleic Acid-Drug Interactons pp. 331-353.
W. D. Wilson et al; Molecular Factors that Control the Nucleic Acid Binding Mode Selection by Unfused Aromatic Cations; Department of Chemistry.
K. Yamamoto et al; Concerted DNA Recognition and Novel Site-Specific Alkylation by Duocarmycin A with Distamycin A; Biochemistry 32, pp. 105-1066 (1993).
C. A. Redi et al; Pericentromeric heterochromatin and A-T contents during Robertsonian fusion in the house mouse; Chromosoma 94, pp. 31-35 (1986).
Bell et al.; Antimicrobiol Agents and Chemotherapy, 37:2668-2673 (1993).
Boykin David W.
Dykstra Christine C.
Perfect John
Tidwell Richard R.
Wilson W. David
Cook Rebecca
Duke University
Georgia State University Research Foundation
University of North Carolina at Chapel Hill
LandOfFree
Methods of combating infectious diseases using dicatoni bis-benz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of combating infectious diseases using dicatoni bis-benz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of combating infectious diseases using dicatoni bis-benz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-962142